TER.CN - TerrAscend Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
3.1300
+0.1600 (+5.39%)
At close: 3:57PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close2.9700
Open0.0000
Bid3.1000 x 0
Ask3.1500 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume66,802
Market Cap230.064M
Beta (5Y Monthly)0.82
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    All
    News
    Press Releases
    • CNW Group

      TerrAscend Announces Date of 2020 Annual General Meeting and Update on Filings

      As a result of the ongoing impact of the COVID-19 pandemic and in accordance with continued public health measures, the Company will host its AGM in a virtual-only format. In addition, the Company announced that it will rely on the temporary blanket relief provided by Canadian Securities Administrators, including the exemptive relief contained in Ontario Instrument 51-504 Temporary Exemptions from Certain Requirements to File or Send Securityholder Materials of the Ontario Securities Commission, to postpone the public filing of its executive compensation disclosure required under National Instrument 51-102 Continuous Disclosure Obligations until such time as the disclosure is filed and delivered to shareholders as part of the Company's information circular relating to its AGM. The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release.

    • CNW Group

      TerrAscend Announces the Opening of Third Apothecarium Dispensary in Pennsylvania

      NEW YORK and TORONTO , June 30, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF), a leading North American cannabis operator, today announced that it will officially open its third retail dispensary location in Pennsylvania on July 6, 2020 . The newly renovated, 5,000 square foot Apothecarium medical dispensary is located at 2701 Lincoln Hwy East, Thorndale, PA.

    • Canadian Securities Exchange Highlights Five Key Takeaways From Its 2020 "Cannabis Month" Podcast and Video Series
      Newsfile

      Canadian Securities Exchange Highlights Five Key Takeaways From Its 2020 "Cannabis Month" Podcast and Video Series

      Toronto, Ontario--(Newsfile Corp. - June 9, 2020) - The Canadian Securities Exchange ("CSE" or "the Exchange") is pleased to announce that it recently completed Cannabis Month, an informative series of podcast interviews with senior executives and other thought leaders across the cannabis sector. The interviews and related content were provided through the CSE's website, YouTube (CSE TV) and Instagram (@CanadianExchange) feeds.The podcast guests included cannabis industry pioneers and entrepreneurs including Bruce Linton (founder of ...

    • CNW Group

      TerrAscend Provides Update and Closing Details for its Oversubscribed US$37 Million Non-Brokered Private Placement

      NEW YORK and TORONTO , May 29, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE:TER, OTCQX: TRSSF), a leading North American cannabis operator, today provided an update regarding its previously announced US$30.0 million non-brokered private placement (the "Offering"). As a result of strong investor demand, the Company has upsized the offering to approximately US$37.0 million , which was oversubscribed and has been fully allocated. TerrAscend closed the second tranche of the Offering on May 28, 2020 , issuing 3,561 Units at an issue price of US$2,000 per Unit resulting in proceeds to the Company of US$7.1 million .

    • CNW Group

      TerrAscend Reports First Quarter Net Sales of $34.8 Million and Adjusted EBITDA of $4.9 Million

      TerrAscend Reports First Quarter Net Sales of $34.8 Million and Adjusted EBITDA of $4.9 Million

    • CNW Group

      TerrAscend Closes Initial Tranche of US$30 Million Non-Brokered Private Placement

      NEW YORK and TORONTO , May 25, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE:TER, OTCQX: TRSSF), a leading North American cannabis operator, today announced the closing of the first tranche of its previously announced non-brokered private placement ("the Offering"), issuing 13,646 Units at an issue price of US$2,000 per Unit resulting in proceeds to the Company of US$27.3 million . Each noninterest-bearing Unit is comprised of one convertible preferred share in the capital of the Company (each, a "Convertible Preferred Share") and one convertible preferred share purchase warrant (each, a "Warrant").

    • CNW Group

      TerrAscend To Host First Quarter 2020 Investor Conference Call

      TerrAscend To Host First Quarter 2020 Investor Conference Call

    • CNW Group

      TerrAscend Announces US$30 Million Non-Brokered Private Placement with Indicative Lead Orders of Approximately US$28 Million

      The Company has received initial investor commitments totaling US$28.0 million , including a US$20.0 million lead order from JW Asset Management LLC ("JW Asset Management") which is expected to close on or about May 21, 2020 , subject to customary closing conditions. The Company intends to use the proceeds from the Offering to fund TerrAscend's growth initiatives including its U.S. expansion strategy, capital expenditures, working capital, and general corporate purposes. The Offering consists of a number of units of the Company (each, a "Unit") issued at the price of $2,000 per Unit (the "Purchase Price").

    • CNW Group

      TerrAscend to Present at Canaccord Genuity's Global Cannabis Conference

      NEW YORK and TORONTO , May 6, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER, OTCQX: TRSSF), a leading North American cannabis operator, today announced that Jason Ackerman , CEO and Executive Chairman, will be presenting at Canaccord Genuity's 4th Annual Global Cannabis Conference. In addition to the webcast presentation, Mr. Ackerman, Jason Wild , Chairman, and Keith Stauffer , Chief Financial Officer, will be conducting virtual one-on-one meetings with investors throughout the afternoon. The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release.

    • TerrAscend Strengthens Partnership with Precision Extraction Solutions
      CNW Group

      TerrAscend Strengthens Partnership with Precision Extraction Solutions

      NEW YORK and TORONTO , May 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), a leading North American cannabis operator, today announced an expanded partnership with Precision Extraction Solutions ("Precision"). Through a newly signed agreement, Precision, a Detroit -based company with an extensive portfolio of cannabis extraction, refinement, and processing technologies, will provide state-of-the-art equipment for TerrAscend's current and future product lines. Precision is designing a multi-solvent lab in TerrAscend's New Jersey facility, currently under construction in Boonton Township .

    • CNW Group

      TerrAscend Announces Appointment of Keith Stauffer as Chief Financial Officer

      TORONTO , April 24, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER, OTCQX: TRSSF), a leading North American cannabis operator, today announced the appointment of Keith Stauffer as Chief Financial Officer ("CFO"). Mr. Stauffer will be based in New York City and is expected to commence his role as CFO on April 27, 2020 , subject to CSE approval. Mr. Stauffer has over 25 years of experience as a business executive holding various senior finance and leadership roles across multiple industries.

    • CNW Group

      TerrAscend Announces Fourth Quarter and Full Year 2019 Financial Results

      TerrAscend Announces Fourth Quarter and Full Year 2019 Financial Results

    • TerrAscend Announces Management Changes
      CNW Group

      TerrAscend Announces Management Changes

      TORONTO , April 14, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), a leading North American cannabis operator, announced today that it has appointed Jason Ackerman as Chief Executive Officer ("CEO"). The Company will also relocate its financial operations to its U.S. headquarters in New York City .

    • TerrAscend to Host Fourth Quarter 2019 Investor Conference Call
      CNW Group

      TerrAscend to Host Fourth Quarter 2019 Investor Conference Call

      TerrAscend to Host Fourth Quarter 2019 Investor Conference Call

    • TerrAscend's Award-Winning Apothecarium to Debut Its First Two Pennsylvania Dispensaries
      CNW Group

      TerrAscend's Award-Winning Apothecarium to Debut Its First Two Pennsylvania Dispensaries

      TORONTO , March 30, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company") a leading North American cannabis operator, today announced it will open its award-winning Apothecarium ("The Apothecarium") branded dispensaries in two Pennsylvania locations; one in Lancaster and a second in Plymouth Meeting . Both locations will serve Pennsylvania medical marijuana patients.

    • TerrAscend Provides Business Update on Response to COVID-19
      CNW Group

      TerrAscend Provides Business Update on Response to COVID-19

      TORONTO , March 27, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), a leading North American Cannabis operator, today provided an update on the current state of its business amid the COVID-19 pandemic. Over the last two weeks, cannabis operations have been deemed essential in the jurisdictions in which TerrAscend is licensed, allowing the Company to remain fully operational and continue to serve customers and patients. To help service increased demand, the Company is hiring additional employees at its retail, cultivation, and processing facilities.

    • TerrAscend Canada Announces C$80.5 Million Financing Arrangement With Canopy Growth Corporation
      CNW Group

      TerrAscend Canada Announces C$80.5 Million Financing Arrangement With Canopy Growth Corporation

      TORONTO , March 11, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend") (CSE:TER, OTCQX: TRSSF), today announced that  TerrAscend Canada Inc. ("TerrAscend Canada"), its wholly owned subsidiary, has entered into a loan financing arrangement  with Canopy Growth Corporation ("Canopy Growth" ) (TSX:WEED, NYSE:CGC) in the amount of C$80.5 million (the "Loan") pursuant to a secured debenture (the "Debenture"). In connection with the funding of the Loan, TerrAscend has issued 17,808,975 common share purchase warrants to Canopy Growth (the "Warrants"). Canopy Growth initially invested in TerrAscend in November 2017 alongside funds managed by TerrAscend Chairman Jason Wild .

    • TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies
      CNW Group

      TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies

      TORONTO , Feb. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first global cannabis company licensed for sales in the U.S., Canada , and the EU, announced today that the terms of its previously announced US$10 million loan (the "Loan") from Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly-owned subsidiary of TerrAscend, have been amended.

    • TerrAscend Utah, LLC Awarded Processing License in Utah
      CNW Group

      TerrAscend Utah, LLC Awarded Processing License in Utah

      TORONTO , Jan. 30, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first global cannabis company licensed for sales in the U.S., Canada , and the EU, announced today that its majority owned subsidiary, TerrAscend Utah, LLC ("TerrAscend Utah") was awarded approval for a Medical Cannabis Processor License by the Utah Department of Agriculture and Food on January 29 , 2020. TerrAscend Utah's processing facility will be located in St George , Utah. "We are pleased St. George will have a company like TerrAscend in our community," said Jeriah Threlfall , President, St George Economic Development.

    • TerrAscend Announces Leadership Changes and Appoints Jason Ackerman Interim CEO
      CNW Group

      TerrAscend Announces Leadership Changes and Appoints Jason Ackerman Interim CEO

      Jason Ackerman , Executive Chairman of the Company, has been named interim CEO, replacing Michael Nashat , who will continue to serve as a member of the Company's Board of Directors and act as a strategic advisor to the Company. The changes are effective immediately.

    • CNW Group

      TerrAscend Announces Termination of Gravitas Nevada Ltd. Acquisition

      TORONTO , Jan. 27, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the U.S., and the EU, today announced the termination of the Securities Purchase Agreement (the "Agreement"), pursuant to which TerrAscend would have acquired all of the issued and outstanding equity interests of Gravitas Nevada Ltd. ("Gravitas"), a vertically-integrated business engaged in the cultivation, processing, packaging and dispensing of cannabis and cannabis related products in Nevada . Gravitas operates a retail cannabis dispensary in Las Vegas, Nevada under the trade name "The Apothecarium."  The transaction, for $33 .5mm in cash and 625 proportionate voting shares in the equity of TerrAscend equivalent to 625,000 common shares of the Company, was originally announced on February 11 , 2019.

    • TerrAscend Awarded Permit to Cultivate by New Jersey Department of Health
      CNW Group

      TerrAscend Awarded Permit to Cultivate by New Jersey Department of Health

      TORONTO , Jan. 16, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the U.S., and the EU, today announced that TerrAscend NJ, LLC ("TerrAscend NJ") has been issued a permit to cultivate medical marijuana by the New Jersey Department of Health ("NJ DOH"). Cultivation operations will commence immediately at its facility in Boonton Township , located in northern New Jersey . In December 2018 , TerrAscend was awarded the right to apply for one of six permits, out of 146 applications, for a vertically-integrated permit to cultivate, process and dispense medical cannabis in the State of New Jersey .

    • TerrAscend Announces Closing on Upsized US$33.5 Million Non-Brokered Private Placement
      CNW Group

      TerrAscend Announces Closing on Upsized US$33.5 Million Non-Brokered Private Placement

      TORONTO , Jan. 13, 2020 /CNW/ - TerrAscend Corp. (CSE:TER;) ("TerrAscend" or the "Company") has completed its previously announced upsized non-brokered private placement (the "Private Placement") with orders totaling an aggregate amount of approximately US$33.5 million , inclusive of the first tranche of the Private Placement which closed on December 30 , 2019. On January 10, 2019 , the Company closed the second tranche of the Private Placement, issuing 3,450,127 units (each, a "Unit") at an issue price of CAD$2.45 per Unit resulting in proceeds to the Company of CAD$8,452,811 .

    • TerrAscend Provides Update and Closing Details for its Oversubscribed US$20 million Private Placement
      CNW Group

      TerrAscend Provides Update and Closing Details for its Oversubscribed US$20 million Private Placement

      Correspondingly, the Company has increased the offering size to approximately US$30 million which has been fully allocated and is anticipated to close in two tranches. Today the Company closed the first tranche of the Private Placement, issuing 12,968,325 Units at an issue price of CAD$2.45 per Unit resulting in proceeds to the Company of CAD$31,772,412 . Each Unit consists of one common share in the capital of the Company (the "Common Shares") and one Common Share purchase warrant (a "Warrant").

    • CNW Group

      TerrAscend's Jason Ackerman to Present at the AltaCorp/ATB 8th Annual Institutional Investor Conference

      TORONTO , Dec. 24, 2019 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the US, and the EU, today announced that Executive Chairman Jason Ackerman will be speaking in a Fireside Chat at 2pm at the AltaCorp/ATB 8th Annual Institutional Investor Conference in Toronto on Tuesday, January 14, 2020 . As the first North American Operator (NAO), with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use. TerrAscend is the first and only cannabis company with sales in the US, Canada , and Europe .